Friday, June 16, 2017

B - Manuscript development and publishing

Downey SM, Geraci SA. Manuscript development and publishing: a 5-step approach. The American Journal of the Medical Sciences 2017;353(2):132-136
(doi: 10.1016/j.amjms.2016.12.005)

This article articulates a 5-step approach for developing and publishing successfully a manuscript in a peer-reviewed journal. The authors combine existing tutorials with their collective experience. The 5 steps identified instruct would-be authors to: know their material and determine their audience; outline their manuscript; be ethically vigilant; develop individual sections and submit their manuscript; and respond to reviewers׳ comments.
http://www.sciencedirect.com/science/article/pii/S0002962916306486

B - NISO Alternative altmetrics project

Lagace N. NISO Releases recommended practice covering outputs of its multiyear project in alternative assessment metrics. Serials Review 2016;42(4):337-338.
(doi: 10.1080/00987913.2016.1246343)   
 
NISO, the National Information Standards Organization, announced the publication of its latest Recommended Practice, NISO RP-25-2016, Outputs of the NISO Alternative Assessment Metrics Project, in September 2016 http://www.niso.org/apps/group_public/download.php/17091/NISO%20RP-25-2016%20Outputs%20of%20the%20NISO%20Alternative%20Assessment%20Project.pdf This document is the culmination of a two-phase project initialized in 2013 and designed to support the uptake of altmetrics. To further facilitate adoption of these new assessment measures, the scholarly community developed consensus work via NISO that addresses several areas of the altmetric environment: definitions and use cases; persistent identifiers, output types, and data metrics; and data quality.
http://www.tandfonline.com/doi/full/10.1080/00987913.2016.1246343?scroll=top&needAccess=true



B - European Commission OA publishing platform


Banks M. European Commission moves into publishing. Physics World 2017;30(5):6.
Reports that the European Commission is proposing to launch its own open-access publishing platform for papers that emerge from its Horizon 2020 programme.. It would be similar to that launched last year by the Wellcome Trust.  This aims to publish papers quickly with peer review occurring post publication. The Bill & Melinda Gates Foundation has also announced that Gates Open Research will launch later this year. These developments present further options for open-access publishing to those provided by regular journals.

Thursday, June 15, 2017

B - Citation indicators

Davis P. Citation performance indicators - A very short introduction. The Scholarly Kitchen 2017 May 15

This post provides a brief summary of the main citation indicators used today. It is not intended to be comprehensive, nor to opine on which indicator is best. The goal  is simply to highlight their salient strengths and weaknesses. These citation indicators are grouped based on the design of their algorithm: the group Ratio-based indicators is built on the same model as the Impact Factor, by dividing citations counts by document counts; the group Portfolio-based indicators calculates a score based on a ranked set of documents; and the last group Network-based indicators seeks to measure influence within a larger citation network.
 https://scholarlykitchen.sspnet.org/2017/05/15/citation-performance-indicators-short-introduction/

B - Should authors suggest peer reviewers?

Teixeira da Silva JA, Al-Khatib A. Should authors be requested to suggest peer reviewers? Science and Engineering Ethics 2017 Feb. 2
(doi: 10.1007/s11948-016-9842-6)

The authors of this paper query the ethics, fairness and validity of the request, by editors, of authors to suggest peer reviewers during the submission process. An author-suggested peer reviewer choice might tempt authors to seek reviewers who might be more receptive or sympathetic to the authors’ message or results, and thus favor the outcome of that paper. Authors should thus not be placed in such a potentially ethically compromising situation, especially as a mandatory condition for submission.
https://link.springer.com/article/10.1007%2Fs11948-016-9842-6

B - Sharing of copyrighted papers

Schiermeier Q. Science publishers try new tack on copyright breaches. Nature 2017;545(7653):145-146
(doi: 10.1038/545145a)

Rise in copyright breaches prompts industry to discuss ways to allow ‘fair sharing’ of articles. Science publishers seem to be changing tack in their approach to researchers who breach copyright. Instead of demanding that scientists or network operators take their papers down, some publishers are clubbing together to create systems for legal sharing of articles — called fair sharing — which could also help them to track the extent to which scientists share paywalled articles online.
https://www.nature.com/news/science-publishers-try-new-tack-to-combat-unauthorized-paper-sharing-1.21959

Wednesday, June 14, 2017

B - Bioethics over the past 40 years

Jin P, Hakkarinen M. Highlights in bioethics through 40 years: a quantitative analysis of top-cited journal articles. Journal of Epidemiology & Community Health




B - Non-English papers in scholarly communication

Liu W. The changing role of non-English papers in scholarly communication: evidence from Web of Science's three journal citation indexes. Learned Publishing 2017;30(2):115-123
(doi: 10.1002/leap.1089)

Non-English languages are widely used, but their roles in scholarly communication are relatively under-explored. This study shows that English is increasingly being used as the dominating language from natural sciences and social sciences to arts and humanities. However, a large number of non-English papers can be found in some applied disciplines of sciences and social sciences, and non-English papers have consistently played important role in arts and humanities disciplines from the beginning of 1975.
http://onlinelibrary.wiley.com/doi/10.1002/leap.1089/full


B - Funder interference in addiction research

Miller P, Martino F, Gross S, et al. Funder interference in addiction research: an international survey of authors. Addictive Behaviors 2017;72:100-105
(doi: 10.1016/j.addbeh.2017.03.026)

This study investigates funder (e.g. industry, government or charity) interference in addiction science. Interference appears to be common by governments and internationally, and similar proportions of reported interference from commercial and government funders were found. Strategies to increase transparency in the addiction science literature, including mandatory author declarations concerning the role of the funder, are necessary internationally.
http://www.sciencedirect.com/science/article/pii/S0306460317301363

Tuesday, June 13, 2017

B - A review of data sharing policies

Vasilevsky NA, Minnier J, Haendel MA, et al. Reproducible and reusable research: are journal data sharing policies meeting the mark? PeerJ 2017 Apr 25;5:e3208
(doi: 10.7717/peerj.3208.eCollection2017)

Publishers could play an important role in facilitating and enforcing data sharing; however, many journals have not yet implemented data sharing policies and the requirements vary widely across journals. This study analyzed the pervasiveness and quality of data sharing policies in 318 biomedical journals . Results showed that only a minority of biomedical journals require data sharing, and a significant association between higher Impact Factors and journals with a data sharing requirement.
https://peerj.com/articles/3208/

B - Data authorship

Bierer BE, Crosas M, Pierce HH. Data authorship as an incentive to data sharing. New England Journal of Medicine 2017;376:1684-1687
(doi: 10.1056/NEJMsb1616595)

The use of research data by persons other than those who originally gathered the data is termed “data sharing". Data sharing creates an obligation for the original investigators who obtain funding, design studies, collect and analyze data, and publish results to make their curated data and associated metadata available to third parties. The authors believe that both as a matter of fairness and as a matter of providing an incentive for data sharing, the persons who initially gathered the data should receive appropriate and standardized credit that can be used for academic advancement, for grant applications, and in broader situations.
http://www.nejm.org/doi/10.1056/NEJMsb1616595


B - Potential predatory and legitimate biomedical journals: a comparison

Shamseer L, Moher D, Maduekwe O, et al. Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison. BMC Medicine 2017;15:28
(doi: 10.1186/s12916-017-0785-9)

The authors carried out a cross-sectional comparison of characteristics of three types of biomedical journals: potential predatory, presumed legitimate open access, and presumed legitimate subscription-based journals. Thirteen evidence-based characteristics by which predatory journals may potentially be distinguished from presumed legitimate journals were identified.
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0785-9



B - Statement on good science publishing

Wakeford R. Academies outline principles of good science publishing. Journal of Radiological Protection 2017;37(1):312-315
(doi: 10.1088/1361-6498/aa58f9)

 A join statement was published on 13 December 2016 by the UK Royal Society and the National Academies of France and Germany that outlines the best practice for high quality science publishing.
A set of principles define a number of minimum conditions which should be satisfied in order to earn the label of "scientific journal".
http://iopscience.iop.org/article/10.1088/1361-6498/aa58f9/meta

B - Single IRBs in multisite trials

Klitzman R, Pivovarova E, Lidz CW. Single IRBs in multisite trials. Question posed by the new NIH policy. JAMA 2017;317(20):2061-2062
(doi: 10.1001/jama.2017.4624)

The National Institutes of Health (NIH) announced a new policy (effective September 25, 2017) to mandate that nonexempt multisite research with humans funded by the NIH be reviewed by a single institutional review boards (IRBs). Underlying the policy is the belief that the use of single IRBs for multisite studies avoids duplicate and possibly conflicting IRB reviews and thereby streamlines and accelerates the review process.
https://www.ncbi.nlm.nih.gov/pubmed/28445582